Bussiere JL - Search Results

1

Developmental and reproductive toxicology studies in nonhuman primates.

Chellman GJ, Bussiere JL, Makori N, Martin PL, Ooshima Y, Weinbauer GF. Chellman GJ, et al. Among authors: bussiere jl. Birth Defects Res B Dev Reprod Toxicol. 2009 Dec;86(6):446-62. doi: 10.1002/bdrb.20216. Birth Defects Res B Dev Reprod Toxicol. 2009. PMID: 20025046 Review.

2

Placental transfer of a fully human IgG2 monoclonal antibody in the cynomolgus monkey, rat, and rabbit: a comparative assessment from during organogenesis to late gestation.

Moffat GJ, Retter MW, Kwon G, Loomis M, Hock MB, Hall C, Bussiere J, Lewis EM, Chellman GJ. Moffat GJ, et al. Birth Defects Res B Dev Reprod Toxicol. 2014 Apr;101(2):178-88. doi: 10.1002/bdrb.21105. Birth Defects Res B Dev Reprod Toxicol. 2014. PMID: 24753333

3

Reproductive toxicity of denosumab in cynomolgus monkeys.

Bussiere JL, Pyrah I, Boyce R, Branstetter D, Loomis M, Andrews-Cleavenger D, Farman C, Elliott G, Chellman G. Bussiere JL, et al. Reprod Toxicol. 2013 Dec;42:27-40. doi: 10.1016/j.reprotox.2013.07.018. Epub 2013 Jul 22. Reprod Toxicol. 2013. PMID: 23886817

4

Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period.

Boyce RW, Varela A, Chouinard L, Bussiere JL, Chellman GJ, Ominsky MS, Pyrah IT. Boyce RW, et al. Among authors: bussiere jl. Bone. 2014 Jul;64:314-25. doi: 10.1016/j.bone.2014.04.002. Epub 2014 Apr 13. Bone. 2014. PMID: 24727159

5

Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine.

Bussiere JL, Davies R, Dean C, Xu C, Kim KH, Vargas HM, Chellman GJ, Balasubramanian G, Rubio-Beltran E, MaassenVanDenBrink A, Monticello TM. Bussiere JL, et al. Regul Toxicol Pharmacol. 2019 Aug;106:224-238. doi: 10.1016/j.yrtph.2019.05.013. Epub 2019 May 11. Regul Toxicol Pharmacol. 2019. PMID: 31085251 Free article. Review.

6

Alternative strategies for toxicity testing of species-specific biopharmaceuticals.

Bussiere JL, Martin P, Horner M, Couch J, Flaherty M, Andrews L, Beyer J, Horvath C. Bussiere JL, et al. Int J Toxicol. 2009 May-Jun;28(3):230-53. doi: 10.1177/1091581809337262. Int J Toxicol. 2009. PMID: 19546261 Review.

7

Species selection considerations for preclinical toxicology studies for biotherapeutics.

Bussiere JL. Bussiere JL. Expert Opin Drug Metab Toxicol. 2008 Jul;4(7):871-7. doi: 10.1517/17425255.4.7.871. Expert Opin Drug Metab Toxicol. 2008. PMID: 18624676 Review.

8

Immunogenicity assessment in non-clinical studies.

Swanson SJ, Bussiere J. Swanson SJ, et al. Curr Opin Microbiol. 2012 Jun;15(3):337-47. doi: 10.1016/j.mib.2012.05.015. Epub 2012 Jul 4. Curr Opin Microbiol. 2012. PMID: 22770538 Review.

9

A comparison of effects on reproduction and neonatal development in cynomolgus monkeys given human soluble IL-4R and mice given murine soluble IL-4R.

Carlock LL, Cowan LA, Oneda S, Hoberman A, Wang DD, Hanna R, Bussiere JL. Carlock LL, et al. Among authors: bussiere jl. Regul Toxicol Pharmacol. 2009 Apr;53(3):226-34. doi: 10.1016/j.yrtph.2009.02.001. Epub 2009 Feb 13. Regul Toxicol Pharmacol. 2009. PMID: 19217923

10

Assessment of menstrual cycle length in cynomolgus monkeys as a female fertility endpoint of a biopharmaceutical in a 6 month toxicity study.

Bussiere JL, Moffat G, Zhou L, Tarlo KS. Bussiere JL, et al. Regul Toxicol Pharmacol. 2013 Aug;66(3):269-78. doi: 10.1016/j.yrtph.2013.05.002. Epub 2013 May 13. Regul Toxicol Pharmacol. 2013. PMID: 23680404

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page